EDVA Endovia Health Sciences, Inc.
$0.16▼ -1.44%
Healthcare
Other
Volume 242.6K
Avg Volume (10D) 463.4K
Key Metrics & Fundamentals
Market Cap
$1.75M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.13 - 9.04
% vs 50 MA
-33.49%
% vs 200 MA
-85.44%
RSI-14
39.7
MACD Histogram
+0.0100
Beta (1Y vs SPY)
2.89
Free Cash Flow
-$1.09M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$1.76M
COGS
$0
Operating Exp
$2.01M
Operating Income
-$2.01M
EBIT
-$2.01M
Pretax Income
-$2.01M
Net Income
-$2.05M
EPS (Diluted)
-0.79
Price & Volume History
Loading chart…
Recent News
Endovia and Lupvindol BioSciences Announce FDA Determination that CannEpil® for Canine Bone Cancer Pain Qualifies as a Minor Use, Establishing Eligibility for Conditional Approval Pathway
GlobeNewswire · Oct 5, 2026 8:45 AM ET
Endovia Health Sciences Closes Initial Funding to Accelerate CannEpil® Development Amid Growing Federal Support for Botanical Drug Pathways
GlobeNewswire · Sep 22, 2026 9:30 AM ET
Endovia Health Sciences Welcomes Historic Shift in Federal Cannabinoid Policy; Advances CannEpil® FDA Submission and Expands Development Pipeline
GlobeNewswire · Aug 31, 2026 8:30 AM ET
Endovia Health Sciences, formerly Splash Beverage, Achieves First FDA Regulatory Milestone for CannEpil® Veterinary Development Program
GlobeNewswire · Aug 25, 2026 8:30 AM ET
Splash Beverage Group to Become Endovia Health Sciences; New NYSE American Ticker “EDVA” Effective Monday
GlobeNewswire · Aug 21, 2026 8:38 AM ET
Financial Overview - Income Statement
Quarterly
Mar 2026
See EDVA's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.